Trial Profile
A study evaluating early changes in liver fibrosis markers in hepatitis C virus-infected patients treated with sofosbuvir based antiviral regimens.
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 15 Feb 2017
Price :
$35
*
At a glance
- Drugs Sofosbuvir (Primary) ; Peginterferon; Ribavirin; Simeprevir
- Indications Hepatitis C
- Focus Pharmacodynamics; Therapeutic Use
- 15 Feb 2017 New trial record